Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Overweight on Eli Lilly, Raises Price Target to $275

Morgan Stanley maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $207 to $275.
byBenzinga Newsdesk
August 5, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $207 to $275.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0